Live from the NIH registry
Studies recruiting near Dallas right now
Top 25 of 1,857 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Medical City Dallas Hospital — Dallas, Texas (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
Texas Oncology — Dallas, Texas (2.4 mi)
· Sponsor: Acepodia Biotech, Inc.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Texas Oncology DFW — Dallas, Texas (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
Children's Medical Center Dallas — Dallas, Texas (2.4 mi)
· Sponsor: Azafaros B.V.
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Physical Inactivity, Phosphate Overload
N/A
Interventional 124 participants sought
University of Texas Southwestern — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care — Waxahachie, Texas (28.5 mi)
· Sponsor: R1 Therapeutics
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Tekton Research — McKinney, Texas (29.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Texas Dermatology Research Center — Dallas, Texas (2.4 mi)
· Sponsor: Takeda
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
Cancer
N/A
Observational 10,000 participants sought
UT Southwestern Medical Centre — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Dallas, Texas (2.4 mi)
· Sponsor: AstraZeneca
Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
N/A
Interventional 300 participants sought
Dallas ENT — Dallas, Texas (2.4 mi)
· Sponsor: Airiver Medical, Inc.
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
North Texas Endocrine Center — Dallas, Texas (2.4 mi)
· Sponsor: Novo Nordisk A/S
Prospective Evaluation of Treatment for Clubfoot
Clubfoot Deformity
N/A
Observational 2,500 participants sought
Texas Scottish Rite Hospital for Children — Dallas, Texas (2.4 mi)
· Sponsor: Texas Scottish Rite Hospital for Children
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
UT Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Medstar Health Research Institute
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Parkland Health and Hospital System — Dallas, Texas (2.4 mi)
· Sponsor: Eli Lilly and Company
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Texas Oncology - Baylor Charles A. Sammons Cancer Center — Dallas, Texas (2.4 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Parkland Memorial Hospital — Dallas, Texas (2.4 mi)
· Sponsor: SWOG Cancer Research Network
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — Irving, Texas (10.7 mi)
· Sponsor: Pasithea Therapeutics Corp.
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
NEXT Oncology Dallas — Irving, Texas (10.7 mi)
· Sponsor: Astellas Pharma Inc
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Metroplex Pulmonary & Sleep Center — McKinney, Texas (29.3 mi)
· Sponsor: Philip Morris Products S.A.
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Cardiomyopathies, Heart Failure
N/A
Interventional 300 participants sought
CardioVoyage — McKinney, Texas (29.3 mi)
· Sponsor: Zoll Medical Corporation
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
UT Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Novartis Pharmaceuticals
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Primary Open Angle Glaucoma, Open Angle Glaucoma
N/A
Interventional 129 participants sought
Glaucoma Associates of Texas — Dallas, Texas (2.4 mi)
· Sponsor: Sanoculis Ltd
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
NEXT Dallas - Oncology Department — Irving, Texas (10.7 mi)
· Sponsor: Bayer
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
UT Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Guardant Health, Inc.